Kestra Advisory Services’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,100
| Closed | -$48.3K | – | 2217 |
|
|
2023
Q1 | $48.3K | Hold |
26,100
| – | – | ﹤0.01% | 1996 |
|
|
2022
Q4 | $29K | Sell |
26,100
-10,250
| -28% | -$11.4K | ﹤0.01% | 2208 |
|
|
2022
Q3 | $85K | Buy |
36,350
+10,100
| +38% | +$23.6K | ﹤0.01% | 1999 |
|
|
2022
Q2 | $80K | Buy |
26,250
+800
| +3% | +$2.44K | ﹤0.01% | 2006 |
|
|
2022
Q1 | $173K | Hold |
25,450
| – | – | ﹤0.01% | 1877 |
|
|
2021
Q4 | $213K | Hold |
25,450
| – | – | ﹤0.01% | 1841 |
|
|
2021
Q3 | $189K | Hold |
25,450
| – | – | ﹤0.01% | 1984 |
|
|
2021
Q2 | $173K | Sell |
25,450
-1
| -0% | -$7 | ﹤0.01% | 1894 |
|
|
2021
Q1 | $261K | Sell |
25,451
-10,249
| -29% | -$105K | ﹤0.01% | 1550 |
|
|
2020
Q4 | $238K | Buy |
35,700
+10,250
| +40% | +$68.3K | ﹤0.01% | 1609 |
|
|
2020
Q3 | $208K | Buy |
+25,450
| New | +$208K | ﹤0.01% | 1281 |
|